Latest In: tuberous sclerosis complex

cannabidiol cbd Dravet syndrome Epidiolex FDA GW Pharmaceuticals Lennox-Gastaut syndrome tuberous sclerosis complex U.S. Food and Drug Administration

FDA approves GW Pharmaceuticals’ cannabis drug for new indication

CBD drug Epidiolex received approval from the U.S. Food and Drug Administration to treat seizures associated with a…

News August 3
MJBizCon Logo